Informations sur le produit
Nom :
CDDO-EA
Description :
CDDO-EA is a synthetic compound that is being studied for its potential as an anti-cancer therapy. This agent has shown to have growth factor-β1 response elements and can be used as an experimental model for proton irradiation. CDDO-EA has been shown to work by inhibiting the production of reactive oxygen species that are produced in response to oxidative injury, which may lead to cancer. CDDO-EA also promotes the development of the M2 phenotype, which suppresses tumor growth and causes myeloid-derived suppressors (MDS) cells to develop in a tumor microenvironment. These cells produce cytokines that promote an anti-tumor immune response.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
518.73 g/mol
Formule :
C33H46N2O3
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
